医渡科技有限公司（02158）于2026年3月19日发布翌日披露报表，公告显示公司在香港联交所场内回购2,665,200股普通股，占回购前已发行股份约0.2604%。本次回购价介乎每股5.55港元至5.65港元，合计耗资14,953,728港元（约1495.37万港元）。
经本次回购后，公司已发行股份总数依然为1,072,650,665股，其中1,020,761,665股为已发行股份（不包括库存股份），库存股份数则增至51,889,000股。
公告同时显示，此次回购基于公司于2025年8月29日通过的购回授权，剩余可回购股份数量为106,455,574股。截至公告日，公司已合计回购48,997,900股，占授权时已发行股本约4.6027%。
公司强调，本次股份回购及后续安排均严格遵守香港联交所证券上市规则及相关法律法规。公告由公司董事宫盈盈正式签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.